A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women

✍ Scribed by T. Cigler; D. Tu; M. J. Yaffe; B. Findlay; S. Verma; D. Johnston; H. Richardson; H. Hu; S. Qi; P. E. Goss

• Publisher: Springer US
• Year: 2009
• Tongue: English
• Weight: 179 KB
• Volume: 120
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-009-0662-0